NMN (nicotinamide mononucleotide) has attracted substantial scientific attention over the past decade — driven by research into NAD+ biology and the role of NAD+ decline in aging and metabolic function. This post covers the research landscape clearly and without overclaiming what the science has established. Informational only — not medical advice.*

What NAD+ Is and Why It Matters

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It plays an essential role in cellular energy metabolism — specifically in the electron transport chain that generates ATP, the primary energy currency of cells.* Without NAD+, cells cannot produce energy efficiently.*

Beyond energy metabolism, NAD+ is a substrate for several enzyme classes whose functions extend across cellular repair, gene expression regulation, and stress response:*

• Sirtuins (SIRT1-7): NAD+-dependent deacetylases involved in gene silencing, DNA repair, and metabolic regulation.* Sirtuin activity is directly dependent on NAD+ availability — without adequate NAD+, sirtuins cannot function.*
• PARPs (poly-ADP-ribose polymerases): NAD+-consuming enzymes involved in DNA damage repair.* PARP activation consumes NAD+ rapidly — a significant drain on cellular NAD+ pools following DNA damage.*
• CD38/CD157: NAD+ hydrolases involved in calcium signalling and immune function.*

NAD+ Decline with Age

NAD+ levels decline with age — a phenomenon documented across multiple species including humans.* The reasons for this decline are multiple: reduced biosynthesis efficiency, increased consumption by DNA repair enzymes (PARPs) responding to accumulated DNA damage, and increased CD38 activity with age.* The functional consequences of this decline have been a major focus of aging biology research.*

David Sinclair (Harvard), Johan Auwerx (EPFL), and Shin-ichiro Imai (Washington University) are among the researchers who have published extensively on NAD+ biology and its relationship to aging biology — providing the scientific foundation for current interest in NAD+ precursor supplementation.*

Where NMN Fits In

NMN is a direct precursor to NAD+ in the biosynthesis pathway. Cells can convert NMN to NAD+ through the action of NMN adenylyltransferases (NMNATs).* Supplemental NMN provides substrate for this conversion, supporting the body’s NAD+ production capacity.*

Animal research — primarily in mice — has shown that NMN supplementation can significantly raise tissue NAD+ levels and is associated with a range of metabolic and physiological effects.* Human clinical research is more recent and more limited in scale, but preliminary trials have demonstrated that oral NMN supplementation raises NAD+ levels in blood.* Imai et al.’s 2023 clinical trial in older men showed that NMN supplementation improved muscle insulin sensitivity — one of the first human trials to demonstrate a functional metabolic outcome alongside NAD+ elevation.*

NMN vs NR: The Precursor Comparison

NR (nicotinamide riboside) is another NAD+ precursor that has been more extensively studied in human clinical trials. The two differ in their conversion pathways to NAD+: NR is converted to NMN before becoming NAD+, while NMN converts directly.* Whether this pathway difference translates to meaningful differences in human NAD+ elevation is an active research question.* Both have shown NAD+-raising activity in human trials; the field has not yet established a clear superiority of one over the other.*

Sierra Life Sciences NMN

Our NMN Cellular Performance (Nicotinamide) is manufactured at our cGMP facility to the same quality standard as our full product range — identity and potency tested, batch documented, facility compliant with 21 CFR Part 111.

Related reading: Melatonin as an Antioxidant: The Research | Acetyl-L-Carnitine 1000mg

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Informational only — research citations are for educational purposes. Not medical advice. Consult your healthcare provider before use.